SciELO - Scientific Electronic Library Online

 
vol.42 número2 índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Hematology, Transfusion and Cell Therapy

versão impressa ISSN 2531-1379versão On-line ISSN 2531-1387

Resumo

PERINI, Guilherme Fleury et al. How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation. Hematol., Transfus. Cell Ther. [online]. 2020, vol.42, n.2, pp.103-110.  Epub 24-Jul-2020. ISSN 2531-1387.  http://dx.doi.org/10.1016/j.htct.2020.04.002.

The novel Coronavirus (CoVid-19) outbreak is now consider a world pandemic, affecting more than 1,300,000 people worldwide. Cancer patients are in risk for severe disease, including a higher risk of intensive care unit (ICU) admission, need for invasive ventilation or death. Management of patients with lymphoid malignancies can be challenging during the outbreak, due to need of multiple hospital visits and admissions, immunosuppression and need for chemotherapy, radiotherapy and stem cell transplantation. In this article, we will focus on the practical management of patients with lymphoid malignancies during the COVID-19 pandemic, focusing on minimizing the risk for patients.

Palavras-chave : CoVid; CoVId-19; Coronavirus; Lymphoma; Chronic lymphocytic leukemia; Lymphoid malignancies.

        · texto em Inglês     · Inglês ( pdf )